Cover Image

Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain

Phosphodiesterases (PDEs) are enzymes that play a major role in cell signalling by hydrolysing the secondary messengers cyclic adenosine monophosphate (cAMP) and/or cyclic guanosine monophosphate (cGMP) throughout the body and brain. Altered cyclic nucleotide-mediated signalling has been associated...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jianrong Liu (Author), Barbara Wenzel (Author), Sladjana Dukic-Stefanovic (Author), Rodrigo Teodoro (Author), Friedrich-Alexander Ludwig (Author), Winnie Deuther-Conrad (Author), Susann Schröder (Author), Jean-Michel Chezal (Author), Emmanuel Moreau (Author), Peter Brust (Author), Aurélie Maisonial-Besset (Author)
Format:	Book
Published:	MDPI AG, 2016-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Radiosynthesis and Preclinical Evaluation of an <sup>18</sup>F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)
by: Barbara Wenzel, et al.
Published: (2022)

Radiosynthesis and Radiotracer Properties of a 7-(2-[18F]Fluoroethoxy)-6-methoxypyrrolidinylquinazoline for Imaging of Phosphodiesterase 10A with PET
by: Detlef Briel, et al.
Published: (2012)

Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A<sub>2B</sub> Receptor Binding Affinity
by: Marcel Lindemann, et al.
Published: (2021)

Improved automated one-pot two-step radiosynthesis of (S)-[18F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
by: Aurélie Maisonial-Besset, et al.
Published: (2024)

Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis
by: Ying Liu, et al.
Published: (2024)

Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties
by: Kamelia M. Amin, et al.
Published: (2022)

Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
by: Jonathan E. Phillips
Published: (2020)

Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis
by: Licia Totani, et al.
Published: (2021)

Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development
by: Gülru Kayık, et al.
Published: (2017)

Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [<sup>18</sup>F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain
by: Oliver Clauß, et al.
Published: (2022)

Discovery of a highly specific 18F-labeled PET ligand for phosphodiesterase 10A enabled by novel spirocyclic iodonium ylide radiofluorination
by: Zhiwei Xiao, et al.
Published: (2022)

Repurposing Phosphodiesterase-5 inhibitors as chemoadjuvants
by: Amit K. Tiwari, et al.
Published: (2013)

Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
by: Franziska Mitrach, et al.
Published: (2022)

Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis
by: Guo Yuh-Cherng, et al.
Published: (2010)

Validated stability-indicating HPLC-DAD method for determination of the phosphodiesterase (PDE-4) inhibitor roflumilast
by: Tarek S. Belal, et al.
Published: (2014)

Population genetics of PDE4B (phosphodiesterase‐4B) in neglected Native Americans: Implications for cancer pharmacogenetics
by: Rennan Garcias Moreira, et al.
Published: (2022)

PDE5 Inhibitors As Potential Tools In The Treatment Of Cystic Fibrosis
by: Sabrina eNoel, et al.
Published: (2012)

Comparative dissolution study on counterfeit medicines of PDE-5 inhibitors
by: E. Deconinck, et al.
Published: (2014)

Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target.
by: Thavy Long, et al.
Published: (2017)

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives
by: Ahmed K. ElHady, et al.
Published: (2023)

Stimulation of Neural Stem Cell Proliferation by Inhibition of Phosphodiesterase 5
by: Ana I. Santos, et al.
Published: (2014)

A Perspective on Natural and Nature-Inspired Small Molecules Targeting Phosphodiesterase 9 (PDE9): Chances and Challenges against Neurodegeneration
by: Giovanni Ribaudo, et al.
Published: (2021)

Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
by: Christina Alves Peixoto, et al.
Published: (2015)

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer
by: Rebecca M. Borneman, et al.
Published: (2022)

Computer prediction of biological activity of 2-methyl(phenyl)-6,9-epoksybenzo[g]quinoline-4,5,10-Trion and 5-methyl-(1,2,4-triazolo[4,3-a] quinoline)
by: Yu. V. Karpenko, et al.
Published: (2015)

Synthesis of 5-Benzylamino and 5-Alkylamino-Substituted Pyrimido[4,5-c]quinoline Derivatives as CSNK2A Inhibitors with Antiviral Activity
by: Kesatebrhan Haile Asressu, et al.
Published: (2024)

The Effect of Phosphodiesterase-type 5 Inhibitors on Erectile Function: An Overview of Systematic Reviews
by: Nikolaos Pyrgidis, et al.
Published: (2021)

Mapping Phosphodiesterase 4D (PDE4D) in Macaque Dorsolateral Prefrontal Cortex: Postsynaptic Compartmentalization in Layer III Pyramidal Cell Circuits
by: Dibyadeep Datta, et al.
Published: (2020)

Inhibition of protein kinases by anticancer DNA intercalator, 4-butylaminopyrimido[4',5':4,5]thieno(2,3-b)quinoline
by: HeggoduG. Rohit Kumar, et al.
Published: (2017)

PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
by: M. N. Mamedov, et al.
Published: (2016)

A Convenient Route to New (Radio)Fluorinated and (Radio)Iodinated Cyclic Tyrosine Analogs
by: Maria Noelia Chao, et al.
Published: (2022)

Development of a novel radiofluorinated riboflavin probe for riboflavin receptor-targeting PET imaging
by: Jindian Li, et al.
Published: (2022)

Development of White Cabbage, Coffee, and Red Onion Extracts as Natural Phosphodiesterase-4B (PDE4B) Inhibitors for Cognitive Dysfunction: In Vitro and In Silico Studies
by: Nazir Ahmad, et al.
Published: (2024)

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives
by: Angelis Konstantinopoulos, et al.
Published: (2007)

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives
by: Angelis Konstantinopoulos, et al.
Published: (2007)

Ultrasound‐targeted microbubble destruction mediates PDE5i/NO integration for cavernosum remodeling and penile rehabilitation
by: Wende Yang, et al.
Published: (2023)

In Silico Mapping of Essential Residues in the Catalytic Domain of PDE5 Responsible for Stabilization of Its Commercial Inhibitors
by: Ivan Pires de Oliveira, et al.
Published: (2019)

Quantitation of the A<sub>2A</sub> Adenosine Receptor Density in the Striatum of Mice and Pigs with [<sup>18</sup>F]FLUDA by Positron Emission Tomography
by: Daniel Gündel, et al.
Published: (2022)

Effect of the Phosphodiesterase 5 Inhibitor Sildenafil on Ischemia-Reperfusion-Induced Muscle Mitochondrial Dysfunction and Oxidative Stress
by: Liliane Tetsi, et al.
Published: (2019)

Differential expression and function of PDE8 and PDE4 in effector T cells: Implications for PDE8 as a drug target in inflammation.
by: Amanda G. Vang, et al.
Published: (2016)